|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
US5643579A
(en)
|
1984-11-01 |
1997-07-01 |
American Home Products Corporation |
Oral vaccines
|
|
ZA858044B
(en)
|
1984-11-01 |
1987-05-27 |
American Home Prod |
Oral vaccines
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5223424A
(en)
|
1985-09-06 |
1993-06-29 |
Prutech Research And Development |
Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
|
|
US4790987A
(en)
|
1985-11-15 |
1988-12-13 |
Research Corporation |
Viral glycoprotein subunit vaccine
|
|
US5310668A
(en)
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
|
US5242829A
(en)
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
|
US5294441A
(en)
|
1987-06-04 |
1994-03-15 |
Washington University |
Avirulent microbes and uses therefor: salmonella typhi
|
|
IL86583A0
(en)
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5387744A
(en)
|
1987-06-04 |
1995-02-07 |
Washington University |
Avirulent microbes and uses therefor: Salmonella typhi
|
|
US5112749A
(en)
|
1987-10-02 |
1992-05-12 |
Praxis Biologics, Inc. |
Vaccines for the malaria circumsporozoite protein
|
|
AU625584B2
(en)
|
1989-03-08 |
1992-07-16 |
Health Research Inc. |
Recombinant poxvirus host selection system
|
|
US5225336A
(en)
|
1989-03-08 |
1993-07-06 |
Health Research Incorporated |
Recombinant poxvirus host range selection system
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
DE69027313T2
(de)
|
1989-03-31 |
1997-01-23 |
Univ Washington |
Impfstoffe enthaltende avirulente phop-type mikroorganismen
|
|
ES2070997T3
(es)
|
1989-12-04 |
1995-06-16 |
Akzo Nobel Nv |
Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
|
|
US5294548A
(en)
|
1990-04-02 |
1994-03-15 |
American Biogenetic Sciences, Inc |
Recombianant Hepatitis a virus
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5462734A
(en)
|
1990-11-02 |
1995-10-31 |
Wisconsin Alumni Research Foundation |
Bovine herpesvirus vaccine and method of using same
|
|
US5240703A
(en)
|
1991-03-01 |
1993-08-31 |
Syntro Corporation |
Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
|
|
US5925729A
(en)
*
|
1991-05-23 |
1999-07-20 |
Ludwig Institute For Cancer Research |
Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
|
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5955088A
(en)
|
1992-02-03 |
1999-09-21 |
Cedars-Sinai Medical Center |
Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
|
|
CA2134773A1
(en)
|
1992-06-04 |
1993-12-09 |
Robert J. Debs |
Methods and compositions for in vivo gene therapy
|
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
|
IL108449A
(en)
|
1993-01-26 |
2011-09-27 |
Weiner David B |
Assemblies and methods for delivery of genetic material
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
US5981505A
(en)
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
|
AU700371B2
(en)
|
1993-06-07 |
1999-01-07 |
Genentech Inc. |
Hiv envelope polypeptides
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US6156319A
(en)
|
1994-07-25 |
2000-12-05 |
The Trustees Of The University Of Pennsylvania |
Soluble herpesvirus glycoprotein complex vaccine
|
|
NL9401820A
(nl)
|
1994-11-02 |
1996-06-03 |
Meyn Maschf |
Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
|
|
US5843648A
(en)
*
|
1995-01-10 |
1998-12-01 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
|
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5650309A
(en)
|
1995-05-16 |
1997-07-22 |
The Regents Of The University Of California |
Viral vectors
|
|
US5698202A
(en)
|
1995-06-05 |
1997-12-16 |
The Wistar Institute Of Anatomy & Biology |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
|
|
US7501501B2
(en)
*
|
1995-09-26 |
2009-03-10 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services |
MHC-Class II restricted melanoma antigens and their use in therapeutic methods
|
|
US5840839A
(en)
*
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US6946133B1
(en)
*
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
|
EP0958364A4
(en)
*
|
1996-10-23 |
2001-10-31 |
Univ Pennsylvania |
IMMUNOTHERAPY AND IMPROVED VACCINES
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
DK1023107T3
(da)
|
1997-04-03 |
2006-12-27 |
Electrofect As |
Fremgangsmåde til indgivelse af farmaceutiske præparater og nucleinsyrer i skeletmuskulaturen
|
|
HUP0004589A3
(en)
|
1997-06-30 |
2003-08-28 |
Centre Nat Rech Scient |
Improved method for transferring nucleic acid into the striped muscle and combination therefor
|
|
US20030138808A1
(en)
|
1998-02-19 |
2003-07-24 |
Simard John J.L. |
Expression vectors encoding epitopes of target-associated antigens
|
|
US6697669B2
(en)
|
1998-07-13 |
2004-02-24 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
US6589529B1
(en)
|
1998-10-30 |
2003-07-08 |
Children's Hospital Medical Center |
Rotavirus subunit vaccine
|
|
CA2362873A1
(en)
*
|
1999-03-03 |
2000-09-08 |
The Trustees Of The University Of Pennsylvania |
Vaccines and gene therapy compositions and methods of making and using the same
|
|
US20030215425A1
(en)
*
|
2001-12-07 |
2003-11-20 |
Simard John J. L. |
Epitope synchronization in antigen presenting cells
|
|
CA2405363A1
(en)
*
|
2000-04-28 |
2001-11-08 |
Ctl Immunotherapies Corp. |
Epitope synchronization in antigen presenting cells
|
|
CA2439492A1
(en)
*
|
2001-02-26 |
2002-09-06 |
Imclone Systems Incorporated |
Tri-hybrid melanoma antigen
|
|
US8771702B2
(en)
*
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
EP1260229A3
(en)
|
2001-05-18 |
2002-12-11 |
Sumitomo Pharmaceuticals Company, Limited |
Anti-autoimmune composition comprising inhibitors of growth hormone-releasing factor activity
|
|
JP4273293B2
(ja)
*
|
2001-05-18 |
2009-06-03 |
大日本住友製薬株式会社 |
Ｇｒｆ作用の阻害による新規抗自己免疫疾患剤、及びそのスクリーニング方法
|
|
EP1270732A1
(en)
|
2001-06-21 |
2003-01-02 |
Schuler, Gerold |
Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
|
|
JP3543326B2
(ja)
|
2001-08-30 |
2004-07-14 |
ソニー株式会社 |
情報処理装置および方法、情報処理システム、情報配信装置、記録媒体、並びにプログラム
|
|
DE60238864D1
(de)
|
2001-11-07 |
2011-02-17 |
Mankind Corp |
Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US20040106128A1
(en)
*
|
2002-06-27 |
2004-06-03 |
Majumdar Anish Sen |
Cancer vaccines containing xenogeneic epitopes of telomerase reverse transcriptase
|
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
|
EP2181595A1
(en)
*
|
2002-08-16 |
2010-05-05 |
Yeda Research And Development Company Ltd. |
Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
|
|
EP1553966B1
(en)
*
|
2002-10-03 |
2012-08-01 |
Wyeth Holdings Corporation |
Fusion peptides comprising the human papillomavirus e7 and e6 polypeptides and immunogenic compositions thereof
|
|
CA2504593C
(en)
|
2002-11-04 |
2016-08-09 |
Advisys, Inc. |
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
|
|
WO2004048938A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Protein Design Labs, Inc. |
Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
|
|
KR101199789B1
(ko)
*
|
2003-03-24 |
2012-11-09 |
더 스크립스 리서치 인스티튜트 |
종양 성장 억제 ｄｎａ 백신
|
|
ES2748130T3
(es)
|
2003-05-30 |
2020-03-13 |
Vgxi Inc |
Dispositivos y métodos para la producción de un biomaterial
|
|
EP1687432A4
(en)
|
2003-11-13 |
2008-08-27 |
Sloan Kettering Inst Cancer |
COMPOSITIONS AND METHODS FOR SYNERGISTIC INDUCTION OF ANTITUMOR IMMUNITY
|
|
EP3263032B1
(en)
*
|
2003-12-09 |
2024-01-24 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
|
GB0401876D0
(en)
*
|
2004-01-28 |
2004-03-03 |
Vereniging Het Nl Kanker I |
New use for cancer antigen
|
|
DE102004035227A1
(de)
*
|
2004-07-21 |
2006-02-16 |
Curevac Gmbh |
mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen
|
|
AU2013203229C1
(en)
*
|
2006-07-28 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines and methods for using the same
|
|
CN105063064B
(zh)
|
2006-07-28 |
2024-09-24 |
宾夕法尼亚大学托管会 |
改进的疫苗及其使用方法
|
|
JP2010504356A
(ja)
*
|
2006-09-20 |
2010-02-12 |
ザ ジョンズ ホプキンス ユニバーシティー |
抗ｂ７−ｈ１抗体を用いた癌及び感染性疾患の組合せ療法
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US8097256B2
(en)
*
|
2006-09-28 |
2012-01-17 |
Cedars-Sinai Medical Center |
Cancer vaccines and vaccination methods
|
|
ATE534661T1
(de)
*
|
2006-10-12 |
2011-12-15 |
Angeletti P Ist Richerche Bio |
Fusionsprotein aus telomerase und reverser transkriptase, dafür codierende nukleotide und anwendungen davon
|
|
WO2008053573A1
(fr)
|
2006-10-30 |
2008-05-08 |
National University Corporation Hokkaido University |
Remède pour néoplasme malin
|
|
ES2622418T3
(es)
|
2007-05-23 |
2017-07-06 |
Vgxi, Inc. |
Composición que comprende alta concentración de moléculas biológicamente activas y procesos para preparar la misma
|
|
WO2010050939A1
(en)
|
2008-10-29 |
2010-05-06 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
|
CA2740598C
(en)
|
2008-11-17 |
2018-05-22 |
Mathura P. Ramanathan |
Antigens that elicit immune response against flavivirus and methods of using same
|
|
US8628762B2
(en)
|
2008-12-10 |
2014-01-14 |
Icahn School Of Medicine At Mount Sinai |
T-helper cell type 17 lineage-specific adjuvants, compositions and methods
|
|
CA2653478A1
(en)
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
|
PT2440575E
(pt)
|
2009-06-09 |
2015-02-12 |
Vaxon Biotech |
Identificação, optimização e utilização de epitopos hla-b*0702 partilhados para imunoterapia
|
|
CA2771298A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Allergan, Inc. |
Methods of treating cancer using glucagon-like hormone retargeted endopeptidases
|
|
WO2011073901A1
(en)
|
2009-12-14 |
2011-06-23 |
Koninklijke Philips Electronics N.V. |
Novel tumor markers
|
|
CA2788902C
(en)
*
|
2010-02-08 |
2019-09-03 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
|
|
EP2558109A4
(en)
|
2010-04-16 |
2014-09-24 |
Bellicum Pharmaceuticals Inc |
METHOD FOR TREATING HARD TUMORS
|
|
ES2664872T3
(es)
*
|
2010-06-18 |
2018-04-23 |
Taiho Pharmaceutical Co., Ltd |
Moduladores PRPK-TPRKB y sus usos
|
|
EP3536703B1
(en)
*
|
2010-11-12 |
2021-05-26 |
The Trustees of the University of Pennsylvania |
Consensus prostate antigens, nucleic acid molecules encoding the same and uses thereof
|
|
WO2013019603A2
(en)
*
|
2011-07-29 |
2013-02-07 |
Inovio Pharmaceuticals, Inc. |
Linear expression cassettes and uses thereof
|
|
CA2871711A1
(en)
*
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
|
ES2721159T3
(es)
*
|
2012-12-14 |
2019-07-29 |
Biontech Rna Pharmaceuticals Gmbh |
Antígenos asociados a tumor independientes de MHC novedosos
|
|
MX369709B
(es)
*
|
2013-03-15 |
2019-11-19 |
Univ Pennsylvania |
Vacunación mejorada contra tirosinasa.
|